B cell purification and induction of apoptosis PBMC were washed three times with PBS, absorbed on nylon wool columns (Biotest, Breiech, Germany), and incubated at 37C for 1h. Unabsorbed cells were removed by extensive washing with warm RPMI and B cells were eluted from the column (14). Effluent B cells were collected purity was determined by flow cytometry (91.31.4 % meanSEM). Induction of apoptosis was performed according to the modified method (15). Briefly 6 x 106 tumour B and normal cells were subjected to 5Gy irradiation (Alcyon, CGR, Paris, France). Irradiated cells were suspended in medium and incubated at 37 C and 5% CO2 for 24h. T cell purification PBMC were washed three times with PBS and passed through a nylon wool column (Biotest). The effluent cells were incubated with anti-CD19, CD14, and anti CD56 MidiMACS beads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s instructions and passed through MidiMACS column (Miltenyi Biotec). The purity was checked by flow cytometry (891.9% meanSEM). Cells were resuspended in RPMI 1640 medium (Gibco, BRL, UK) supplemented with 10% heat-inactivated pooled human AB+ serum, 2 mM L-glutamine, 100 IU/ml penicillin and 100g/ml streptomycin (referred to as complete medium). Enzyme- Linked ImmunoSpot Assay (ELISPOT) Identification of IFN- secreting T cells was performed as described earlier (17). Apo-DC, DC-lysate, and DC-RNA (2x104) were added to 2x105 autologous T cells and incubated overnight at 37 C. Ninety six well flat-bottomed nitrocellulose micro titer plates (Millipore AB, Stockholm, Sweden) were coated with anti-human IFN- MAb clone 1-D1K; MABTECH, Sweden) at 4C over night. The antibody-coated plates were then washed with sterile PBS and pre-incubated cells were added to the wells and incubated at 37 C for 24h. Biotinylated anti-IFN- avidin-conjugated alkaline phosphatase and BCIP® (Sigma Diagnostic, St. Louis, MO) were used for developing the color reaction. Spots were counted using an automatic ELISPOT reader (Axioplan2 Microscope reader, Carl Zeiss, Jena, Germany). Similar experiments were also performed using normal DC and B cells from healthy volunteers. RNA extraction and cDNA synthesis T-cells were stimulated in 12-well tissue culture plates (Corning Incorporated 3513, Corning, NY). 2106 T cells and 2105 Apo-DC, DC-lysate, or DC-RNA were cocultured for 18 h in 2 ml RPMI 1640 complete medium. T cells alone and T cells + unpulsed DC were used as 6 controls. Total RNA was extracted from 2x10 T cells, using RNAzol™ B (TEL-TEST Inc, Friendswood, Texas) using guanidine thiocyanate phenol-chloroform extraction method, according to the manufacturer’s recommendation. RNA was denatured at 65 °C for 5 min and immediately chilled on ice. First-strand cDNA synthesis was performed in a 20 l reaction mixture containing 0.5 g RNA in 10 l volume, 4 l 5x buffer (GIBCOBRL, Gaithersburg, MD), 1.5 l dithiothreitol (DTT, 100 mM), 2 l dNTPs (5 mM each, Amersham Biosciences), 1.0 l random hexamer primers (100 pmol/l, Amersham Biosciences), 0.5 l dH2O, 1.0 l M-MLV reverse transcriptase (200 U/l, GIBCOBRL, Gaithersburg, MD USA). The reaction mixture was incubated at 42 °C for 45 min followed by 5 min at 70 °C to inactivate reverse transcriptase and then stored at –20 °C. Real Time quantitative PCR; The cytokine gene expressions were quantified using ABI prism 7700 Sequence Detection system (PE Applied Biosystems, Foster city, CA, USA) as previously described (18). Primers were designed to span exon junction to prevent amplification of any possible contaminating genomic DNA (Table 2). Probes were labeled with FAM (6-carboxyfluoresciein) and TAMRA (6-carboxy-tetramethyl-rodamine). Fluorescence signals were generated during each PCR cycle via 5`-3`exonuclease activity of Ampli Tag Gold DNA polymerase (18).The relative quantitative expression of different cytokine genes in control and subjects cells were determined using the arithmetic equation 2-CT according to PerkinElmer instruction manual. Equal amounts of total RNA were used from all samples to synthesize cDNA using a large volume master mix and equal volumes of cDNA were subsequently used in all assays. The amount of target gene was normalized to an endogenous reference gene (-actin) at each stage. The calculation of CT involves subtraction of Threshold of Cycle (CT) in control cells from that in activated cells for each time point. The relative increase of each cytokine was equal to 2-(CT subjects - CT . CT for control or subject was calculated by subtraction of the endogenous control controls) CT from the target cytokine CT. Accordingly the stimulation index (SI) by RT-QPCR was defined by dividing the relative increase in different cytokine gene expressions in stimulated samples, by those of unstimulated samples. T cell proliferation assay To assess the capability of Apo-DC, DC-lysate, and DC-RNA, to induce an autologous, T cell proliferative response, 2x104 of each of Apo-DC, DC lysate, or DC-RNA were added to 2x105 autologous T cells in a 96-well U-bottom plate in triplicates and incubated at 37 C for 5 days. T cells alone and with unpulsed DC were used as controls to determine baseline proliferation. 3H-thymidine (Amersham Pharmacia biotech) was then added to each well at a concentration of 1 Ci for the final 18 h of culture. The plates were harvested and the incorporated 3H thymidine was quantitated using a beta scintillation counter (Microbeta 1450, Wallac, Turku, Finland). Proliferative responses of autologous T cells from normal, age matched donors induced by Apo-DC, DC-lysate and DC-RNA, using autologous, normal B cells as the antigen source, were also examined (n=3). Sequence of primers and probes for cytokines and ß-actin used in real-time PCR Target sequence Primer Sequence (5’3’) Accession no. Position -actin Sense CGACAGGATGCAGAAGGAGA Probe (X)AAGATCAAGATCATTGCTCCTCCTGAG(Y) Antisense CGTCATACTCCTGCTTGCTG NM-001101 NM-001101 NM-001101 1003-1022 1049-1075 1144-1163 IFN- Sense TCTGCATCGTTTTGGGTTCT Probe (X)TGACCAGAGCATCCAAAAGAGTGTG(Y) Antisense GCAGGCAGGACAACCATTACT X13274 X13274 X13274 143-162 363-387 605-625 GM-CSF Sense ACACAGCCCTGGGAGCAT Probe Antisense (X)ACAGCACTGCCCTCCAACCCC(Y) CTGGCCGGTCTCACTCCT M11734 M11734 M11734 94-111 321-341 443-459 TNF- Sense TGTTGTAGCAAACCCTCAAGC Probe (X)ACACCATCAGCCGCATCGC(Y) Antisense AGTCGGTCACCCTTCTCCA AF043342 AF043342 AF043342 45-65 233-251 377-395 IL-2 Sense GAATGGAATTAATAATTACAAGAATC Probe (X)ACATGCCCAAGAAGGCCACAGAACTG(Y) Antisense ATGTTGTTTCAGATCCCTTTAGTTCCCAGA U25676 U25676 U25676 191-216 250-275 395-423 IL-4 Sense TCTGTTCTTCCTGCTAGCA Probe Antisense (X)TGCTGCCTCCAAGAACACAACTGA(Y) CCGTTTCAGGAATCGGATCA M13982 M13982 M13982 93-111 234-257 371-390 IL-10 Sense GCTGGAGGACTTTAAGGGTTAC Probe (X)AGAACCAAGACCCAGACATCAAGGC(Y) Antisense ACAGGGAAGAAATCGATGACAG M57627 M57627 M57627 240-261 326-350 405-426 Perforin Sense CCAGAAGACCCACCAGGACCAGT NM-005041 Probe (X)TGCCGCTTCTACAGTTTCCATGTGGTACAC(Y) NM-005041 Antisense GGGTGGAGGCGTTGAAGTGGTG NM-005041 X:TAMRA Y:FAM 477-499 526-555 604-625